BREEDLOVE ROBERT CHARLES enters PHATHOM PHARMACEUTICALS, INC. with 55.19K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 5/6/2025ACC: 0000950170-25-064587
Officer· Principal Accounting Officer
Since Feb 2026
55.19K
Baseline shares
91% direct
50.08K
Direct ownership
1 position
56.25K
Derivative underlying
4 instruments
2
Security positions
5.11K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned5.11K
Common Stock
DirectShares owned50.08K
Total
50.08K direct·5.11K indirect55.19K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.11K | Indirect |
| Common Stock | 50.08K | Direct |
| Total | 55.19K | 50.08K direct·5.11K indirect |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
13.50K
Shares owned
N/A
Exercise price
8.35
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
15.75K
Shares owned
N/A
Exercise price
7.6
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
12K
Shares owned
N/A
Exercise price
15.21
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
15K
Shares owned
N/A
Exercise price
5.76
Expiration
—
Exercise window
—
Total
Underlying
56.25K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 8.35 | — | — | 13.50K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.6 | — | — | 15.75K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 15.21 | — | — | 12K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 5.76 | — | — | 15K | N/A |
| Total | 56.25K | 0.00 | ||||